{"value":{"id":1200966,"memberId":4014,"member":null,"memberRole":"Secretary of State for Business, Energy and Industrial Strategy","uin":"HCWS274","dateMade":"2020-06-08T00:00:00","answeringBodyId":201,"answeringBodyName":"Department for Business, Energy and Industrial Strategy","title":"Business Update ","text":"<p>I hereby give notice of the Department for Business, Energy and Industrial Strategy’s intention to seek an advance from the contingencies fund totalling £5,673,000 to enable expenditure on Covid-19 vaccines programme to be spent ahead of the passage of the Supply and Appropriation Act.</p><p> </p><p>The funding is urgently required for HM Government to secure inventory which can be utilised for a number of vaccine, antibody and therapeutic candidates.</p><p>Parliamentary approval for additional resources of £5,673,000 for this new expenditure will be sought in a Main Estimate for the Department for Business, Energy and Industrial Strategy. Pending that approval, urgent expenditure estimated at £5,673,000 will be met by repayable cash advances from the Contingencies Fund.</p><p>The cash advances will be repaid upon receiving Royal Assent on the Supply and Appropriation Bill.</p>","house":"Commons","noticeNumber":1,"hasAttachments":false,"hasLinkedStatements":true,"linkedStatements":[{"linkedStatementId":1200967,"linkType":"JointStatement","linkDate":"2020-06-08T00:00:00"}],"attachments":[]},"links":[{"rel":"self","href":"/Statements/1200966","method":"GET"}]}